Important Updates: Senate Approves Coronavirus Relief Bill: Biden Receives Pfizer-BioNTech Vaccine



Monday saw the occurrence of many important events: political as well as celestial. The winter solstice on Monday, December 21, the day with the longest night, brought some relief to struggling Americans as the long awaited $900 billion Corona Relief Package was finally passed late evening. On Monday, Treasury Secretary of the U.S., Steven Mnuchin said that several Americans would receive the $600 stimulus checks by next week.


Other significant developments include the following:


  1. The United States health authorities are huddled together looking for a way to deal with a new, virulent mutation of the coronavirus that has emerged this winter, in the UK. It spreads faster, at a rate of 70% above usual strains, and has caused panic worldwide. Europe has shut its borders with the UK. Asian and American countries have stopped flights to and from Britain.
  2. On Monday President-elect Joe Biden publicly received a shot of the Pfizer-BioNTech coronavirus vaccine. On Tuesday top federal infectious diseases specialist Anthony S. Fauci and Alex Azar, Health and Human Services Secretary will receive the first dose.
  3. Holiday travel is in full swing despite warnings of the increased spread of the virus. This has been the busiest weekend during the pandemic.
  4. Turning Point USA, a conservative student group, allegedly violated local Covid-19 restrictions this weekend; by holding two large events in Florida. They disregarded requests by authorities’ and went ahead, holding one such event at President Trump’s private club — Mar-a-Lago.
  5. The coronavirus count is now at over 18 million cases and 318,000 fatalities since February, nationwide.



Follow us on Google news for more updates and News


This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.